Vice President, Translational Research

Director, Healthcare Compliance (Global)

Rare Disease Sales Opportunity - Territory Manager (St. Louis, MO)

Senior National Account Director

Manager, Field & Marketing Operations (Speaker Bureau)

Director, Revenue Forecasting and Commercial Performance (North America)

Director, Data Science

Hospital Affairs Lead, Italy

Associate Director, Scientific Communications

Clinical Project Manager

International Brand Manager

Area Development Manager - West

Area Development Manager - South

Area Development Manager - Northwest

International Legal Counsel

Medical Director, UK and Ireland

Sr. Associate, Analytical Chemistry

General Manager, Germany, Switzerland, Austria

Director, Registry Operations

Bilingual Patient Education Manager - Southern California

Hospital Affairs Lead, Spain

Scientific Affairs Manager - Germany (Southwest)

Associate Director, Regulatory Affairs

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

76Bio

A-Alpha Bio

A2 Biotherapeutics

AAVogen

ACELYRIN

ADAXION Therapeutics

AI Proteins

AIRNA Bio

ALX Oncology

AN2 Therapeutics

AOA Dx

ARTBIO

AS2 Bio Inc

AUM BioTech

AVROBIO

Ab Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

Acepodia

Achieve Life Sciences

Acomhal Research

Acrivon Therapeutics

Actym Therapeutics, Inc.

Acutis Diagnostics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Adiso Therapeutics

Aditum Bio

Admera Health

Adverum Biotechnologies

Aeglea BioTherapeutics

Aera Therapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

AgBiome

Agastiya Biotech

Agena Bioscience

AiViva Biopharma

Ainnocence

AivoCode

Aixa Bio

Akero Therapeutics

Akita Biosciences

Akouos

Akttyva Therapeutics

Alamar Biosciences

Aldebaran Therapeutics

Alector

Alida Biosciences

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

Alltrna

AlpaLifeBio

Alpha-9 Oncology

Alphabioregen

AltPep

Alterome Therapeutics

Altis Biosystems

Alto Neuroscience

Alumis

Alveo Technologies

Alveolus Bio

Alzheon

AmbAgon Therapeutics

Amberstone Biosciences

Amolyt Pharma

Amylyx Pharmaceuticals

AnHeart Therapeutics

Anagram Therapeutics

Ancora Biotech LLC

Andes

Andson Biotech

Anebulo Pharmaceuticals

Angiex

Angiocrine Bioscience

Anima Biotech

Ankyra

Annexon Biosciences

Anodyne Nanotech

Anokion

Ansa Biotechnologies

Rhythm Pharmaceuticals is developing drugs that target the leptin-melanocortin signaling pathway to treat patients with obesity. Obesity is the result of many factors that disrupt energy balance, not just due to food consumption. Mutations in the melanocortin-4 receptor (MC4R) pathway are linked with hyperphagia and severe obesity. With the help of their DNA database focused on obesity, Rhythm is mapping the MC4R signaling pathway to understand the functional and clinical relevance of genetic variants to identify effective drug targets. Rhythm has already completed two Phase 3 clinical trials using setmelanotide.

Find a biotech startup job.